Claudia Dompé

Ms. Claudia Dompé


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
CDClaudia Dompé
Claudia Dompé
ACAleksandra Chojnowska
Aleksandra Chojnowska
RRRodryg Ramlau
Rodryg Ramlau
MNMichal Nowicki
Michal Nowicki
CACatherine Alix-Panabières
Catherine Alix-Panabières
JBJoanna Budna-Tukan
Joanna Budna-Tukan
This review delves into the pivotal role of circulating tumor cells (CTCs) in colorectal cancer (CRC) metastasis, focusing on their biological properties, interactions with the immune system, advanced detection techniques, and clinical implications. We explored how metastasis-competent CTCs evade immune surveillance and proliferate, utilizing cutting-edge detection and isolation technologies, such as microfluidic devices and immunological assays, to enhance sensitivity and specificity. The review highlights the significant impact of CTC interactions with immune cells on tumor progression and patient outcomes. It discusses the application of these findings in clinical settings, including non-invasive liquid biopsies for early diagnosis, prognosis, and treatment monitoring. Despite advancements, challenges remain, such as the need for standardized methods to consistently capture and analyze CTCs. Addressing these challenges through further molecular and cellular research on CTCs could lead to improved interventions and outcomes for CRC patients, underscoring the importance of unraveling the complex dynamics of CTCs in cancer progression.

5 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
KBKarolina Buszka
Karolina Buszka
CDClaudia Dompé
Claudia Dompé
KDKinga Derwich
Kinga Derwich
IPIzabela Pieścikowska
Izabela Pieścikowska
Michał NowickiMichał Nowicki
Michał Nowicki
JBJoanna Budna
Joanna Budna
Cancer remains a major global health challenge requiring the development of diagnostic and therapeutic strategies. Liquid biopsy is considered a promising minimally invasive tool for cancer screening, prognosis and treatment monitoring. Recent studies suggest that neutrophil extracellular traps (NETs) may also be potential liquid biopsy markers. NETs are web-like chromatin structures released by neutrophils in response to various stimuli to trap and neutralize pathogens. However, excessive or dysregulated NET formation has been implicated in tumor progression and metastasis. Elevated levels of NETs have been observed in patients with various types of cancer and correlate with disease stage and prognosis. The presence of NET markers such as citrullinated histone H3 (H3Cit), neutrophil elastase (NE) and myeloperoxidase (MPO) has been associated with higher tumor burden and poorer clinical outcomes. Several studies have shown a positive correlation between NET markers and circulating free DNA (cfDNA) levels, suggesting that NETs may increase the sensitivity of liquid biopsy in detecting and monitoring cancer progression. This review examines the role of NETs in the tumor microenvironment, their contribution to cancer progression and metastasis, and their potential use in liquid biopsy and cancer therapy.

Verified
Journal Article
Open access
PDF file
AKAgata Kolecka-Bednarczyk
Agata Kolecka-Bednarczyk
MFMagdalena Frydrychowicz
Magdalena Frydrychowicz
BBBartlomiej Budny
Bartlomiej Budny
Marcin RucinskiMarcin Rucinski
Marcin Rucinski
CDClaudia Dompé
Claudia Dompé
JBJoanna Budna
Joanna Budna
Non-small cell lung cancer (NSCLC) leads as a primary cause of cancer-related premature mortality in Western populations. This study leverages cutting-edge gene-expression-profiling technologies to perform an in-depth molecular characterization of NSCLC specimens, with the objective of uncovering tumor-specific genomic alterations. By employing DNA microarray analysis, our research aims to refine the classification of NSCLC for early detection, guide molecular-targeted treatment approaches, enhance prognostication, and broaden the scientific understanding of the disease’s biology. We identified widespread genomic abnormalities in our samples, including the recurrent loss of chromosomal regions 3p, 5q, 13q, and 21q and the gain of 12p. Furthermore, utilizing Metascape for bioinformatic analysis revealed critical biological pathways disrupted in NSCLC, offering promising leads for novel therapeutic interventions.